Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Delamanid - Otsuka Pharmaceutical

Drug Profile

Delamanid - Otsuka Pharmaceutical

Alternative Names: 6-nitro-2,3-dihydroimidazol - Otsuka Pharmaceutical; Deltyba; OPC-67683

Latest Information Update: 22 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Otsuka Pharmaceutical
  • Developer Mylan; Otsuka Pharmaceutical
  • Class 2 ring heterocyclic compounds; Antituberculars; Nitroimidazoles; Oxazoles; Phenyl ethers; Piperidines; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Tuberculosis
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Tuberculosis

Most Recent Events

  • 25 Oct 2018 Phase-I/II clinical trials in Tuberculosis (Combination therapy) in South Africa (PO) (NCT03678688)
  • 24 Jun 2018 Biomarkers information updated
  • 12 Mar 2018 Registered for Tuberculosis in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top